The global surgical tourniquets market size was valued at USD 511.20 million in 2024 and is projected to reach from USD 548.31 million in 2025 to USD 960.58 million by 2033, growing at a CAGR of 7.26% during the forecast period (2025–2033).
Surgical tourniquets are medical devices used during surgery to temporarily stop blood flow in the limb. They are commonly used in orthopedic surgeries, such as joint replacement surgeries, to create a bloodless field, which enhances the surgeon's visibility and reduces blood loss. Tourniquets can be pneumatic (inflated with air), mechanical (using a screw mechanism), or digital (using a finger or hand to apply pressure). In order to prevent complications such as nerve damage and tissue ischemia, proper application and monitoring of tourniquets is essential.
The surgical tourniquets market is driven by increasing surgical procedures, particularly in orthopedic surgeries, and advancements in tourniquet technology enhancing safety. Growing awareness of blood management strategies and rising trauma cases are also significant factors. Additionally, the expansion of healthcare infrastructure in developing regions contributes to market growth.
The use of surgical tourniquets in emergency and surgery situations is necessary due to a growing number of accidents, falls and sports injuries around the world. Traumatic injuries often require immediate medical attention to control bleeding and stabilize the patient, making tourniquets a critical tool in these scenarios.
For instance,
The market for tourniquets is constantly being innovated by different manufacturers. For example, Sam Medical has launched a SAM XT Extremity Tourniquet that is designed to be quickly deployed in the case of trauma. The innovative design of the tourniquet allows for precise pressure control and ease of use, which makes it ideal for emergency responders as well as military applications.
As a result, the market for surgical tourniquets is booming at a rapid pace, with all the above-mentioned increases in injuries and product launches.
The demand for improved tourniquet systems is driven by an increase in military expenditure and the focus on improving emergency medical responses in combat areas. The introduction of Smart Tactical Application Tourniquet (S.T.A.T.), designed specifically for military use provides rapid application and is effective in controlling severe hemorrhage, making it an essential tool for combat medics.
In addition, in order to improve the survival and treatment of soldiers on the ground, armies all over the world are investing heavily in health technologies. In fact, in 2021, global spending on armed forces was USD 2.1 trillion, according to the Stockholm International Peace Research Institute. In order to ensure the efficient treatment of casualties in combat, significant budgetary allocations are made for modern medical equipment such as tourniquets.
The United States Department of Defense is investing in advanced healthcare technology for its personnel. For instance, the Tactical Combat Casualty Care (TCCC) guidelines emphasize the use of tourniquets as a critical component of life-saving measures on the battlefield.
These statistics show the critical role played by surgical tourniquets in dealing with traumatic injuries and their impact on military investment for technological progress.
The cost of advanced tourniquet systems is very expensive The high cost associated with advanced tourniquet systems can limit their adoption, particularly in low- and middle-income countries. Advanced tourniquet systems, which often feature automated pressure control, safety alarms, and other high-tech functionalities, are expensive to produce and purchase. This financial barrier is making it difficult to acquire and use these devices for healthcare professionals in resource limited settings. The basic mechanical tourniquets can cost between USD 20 and USD 50, while advanced electronic tourniquet systems with features such as automatic pressure regulation or integrated alarms may be priced in the range of several thousand dollars. Depending on the configuration and additional accessories, the automatic tourniquet system is priced from 1500 to 5000 USD.
Thus, the high cost of advanced tourniquet systems poses a significant challenge to their widespread adoption, particularly in regions with constrained healthcare budgets. This financial barrier highlights the need for cost-effective solutions and potential funding support to enhance the availability of these life-saving devices in low- and middle-income countries.
The effectiveness and use of surgical tourniquets has been significantly improved by technological advances such as automatic tourniquet systems with safety features and accurate pressure controls. These innovations represent substantial growth opportunities for the market as they improve patient outcomes, enhance safety and increase efficiency in surgical or emergency settings.
For instance,
Systems like the Stryker SmartPump Tourniquet System offer wireless connectivity and integration with hospital data systems. This allows for real-time monitoring and recording of tourniquet use, which can be critical for post-operative analysis and improving surgical protocols.
These technological advancements, with enhanced features such as automated pressure control, integrated safety systems, and wireless connectivity are expected to improve patient outcomes and drive the adoption of advanced tourniquet systems in both surgical and emergency settings.
| Study Period | 2021-2033 | CAGR | 7.26% |
| Historical Period | 2021-2023 | Forecast Period | 2025-2033 |
| Base Year | 2024 | Base Year Market Size | USD 511.20 million |
| Forecast Year | 2033 | Forecast Year Market Size | USD 960.58 million |
| Largest Market | North America | Fastest Growing Market | Asia Pacific |
North America is the most significant global surgical tourniquets market shareholder and is expected to expand substantially during the forecast period. This region has a well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and a large number of surgical procedures performed annually.
Asia Pacific region is expected to emerge in the market. The market's major impact drivers are the growing preference for trials by global players due to low-cost structures, and higher investment in research and development. Improved reimbursement policies for surgical procedures in some Asia Pacific countries are also expected to drive market growth.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The market is divided into tourniquet systems, tourniquet cuffs, and others. The tourniquet cuffs segment for surgical tourniquets market is dominant. Tourniquet cuffs are the primary component used to apply pressure to a limb, controlling blood flow during surgeries, trauma care, and emergency situations. Their essential role makes them a fundamental part of any tourniquet system. They are further sub-segmented into disposable and reusable cuffs.
Moreover, tourniquet cuffs are used across various medical specialties, including orthopedics, trauma surgery, and emergency medicine. This broad application spectrum contributes to their dominance in the market. The effectiveness and adoption rate of tourniquet cuffs has continued to increase due to advances in technology such as the integration of automatic pressure controls and security features. For instance, a study by BioMed Central (Spring Nature) found that a new elastic tourniquet cuff improved the bloodless surgical field and required less pressure adjustment compared to a conventional cuff in total knee arthroplasty.
As a result, tourniquet cuffs have been the dominant segment of the market due to their essential role, broad use in medical specialties and recent technological developments that improve their effectiveness and adoption.
The market is divided into hospitals and trauma centers, ambulatory surgery centers, defense and others. Hospitals and trauma centers dominate the global surgical tourniquets market due to their high volume of surgical procedures and diverse healthcare specialties. These facilities handle a wide range of cases requiring tourniquets, driving significant demand. For instance, the significant rise in Accident and Emergency (A&E) department attendances in NHS hospitals, reaching 14.4 million in 2020-21, is expected to drive the demand for wound care surgeries. This, in turn, is anticipated to increase the need for pneumatic tourniquets. Hospitals and trauma centers also serve various specialties like orthopedics and emergency medicine, which frequently use tourniquets. With advanced infrastructure and emergency capabilities, these facilities are crucial in driving demand for surgical tourniquets.
Thus, all the above-mentioned factors collectively show that the hospitals and trauma centers are the key end users driving the demand for surgical tourniquets.
Our research analysts report that the tourniquet industry is on a steady growth, fueled by technology advances, increases in surgery and increased focus on safety for patients. In order to introduce novel, lightweight designs with user-friendliness, industry players are active in research and development. Nevertheless, there are still obstacles such as strict regulatory requirements and concerns about injuries to the limbs.
In spite of these challenges, the market offers promising opportunities for growth, particularly in developing countries where healthcare infrastructure is being expanded. Significant developments in the industry's landscape are a growing preference for pneumatic tourniquets because of their efficiency and safety characteristics, as well as an evolution towards disposable tourniquets to prevent infections. Overall, the market outlook remains positive, with a strong potential for growth in the coming years.
